» Articles » PMID: 35426779

Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung Abnormalities

Abstract

Interstitial lung abnormalities (ILAs) are being increasingly identified in clinical practice. In particular, for subpleural nonfibrotic ILAs, the risk of progression over time and the risk factors for progressive behavior are still largely unknown. To determine the age band prevalence of ILAs and the risk of radiological progression of subpleural nonfibrotic ILAs over time in a large health checkup population and to identify how reticulation contributes to the risk of radiological progression. On the basis of the ILAs definition by the Fleischner Society, low-dose chest computed tomography images from the community-dwelling population who have undergone health checkups were evaluated for ILAs. Multivariable logistic regression was used to assess the risk of radiological progression. Among 155,539 individuals, 3,300 (2.1%) were confirmed to have ILAs: the vast majority (81.7%) were defined as subpleural nonfibrotic ILAs. The prevalence of ILAs increased linearly with age ( for trend < 0.0001). Of 454 individuals with subpleural nonfibrotic ILAs, 198 (43.6%) had radiological progression over 4 years. The presence of reticulation on initial imaging was an independent predictor of radiological progression (odds ratio, 1.9; 95% confidence interval, 1.2-3.0;  = 0.0040). No difference in radiological progression was identified between subpleural nonfibrotic ILAs with extensive reticulation and subpleural fibrotic ILAs (73.0% vs. 68.8%;  = 0.7626). The prevalence of ILAs increases linearly with age. Nearly half of subpleural nonfibrotic ILAs progress radiologically over 4 years. The presence of reticulation is a risk factor for radiological progression. Subpleural nonfibrotic ILAs with extensive reticulation are likely to be a feature of subpleural fibrotic ILAs.

Citing Articles

Interstitial Lung Abnormalities: Unraveling the Journey from Incidental Discovery to Clinical Significance.

Gogali A, Kyriakopoulos C, Kostikas K Diagnostics (Basel). 2025; 15(4).

PMID: 40002659 PMC: 11854474. DOI: 10.3390/diagnostics15040509.


Correlation between CT-based phenotypes and serum biomarker in interstitial lung diseases.

Shin B, Oh Y, Kim J, Park S, Lee K, Lee H BMC Pulm Med. 2024; 24(1):523.

PMID: 39427156 PMC: 11490112. DOI: 10.1186/s12890-024-03344-8.


Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis.

Hwang J, You S, Lee Y, Sun J Eur Radiol. 2024; 35(1):276-288.

PMID: 39026064 DOI: 10.1007/s00330-024-10952-9.


"Interstitial lung abnormalities": translation to and use in Portuguese.

Yamanari T, Auad R, Mancano A, Koenigkam-Santos M, Santana P, Souza Junior A Radiol Bras. 2024; 57:e20230114.

PMID: 38993957 PMC: 11235071. DOI: 10.1590/0100-3984.2023.0114-en.


Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis.

Lee H, Kim S, Park Y, Choi S, Lee J, Park J Sci Rep. 2024; 14(1):8857.

PMID: 38632477 PMC: 11024342. DOI: 10.1038/s41598-024-59649-5.